Company: BNBX
Filing Date: 2025-12-22
Form Type: 10-K
Source: 0001104659-25-123342
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-12-22
Form: 10-K
Item: Item 10D
Chunk 2
---
ITEM 10.DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Board of Directors, Executive Officers and Key Employees

The Board of Directors (the “Board of Directors”) currently consists of six members. The term of each Director expires at our next annual meeting or until his or her successor is appointed. Our executive officers are elected by, and serve at the discretion of, the Board of Directors. There are no family relationships between any directors or executive officers.

The ages of the directors and executive officers are shown as of December 15, 2025.

​

Name  ​ ​ ​Ages  ​ ​ ​PositionClay Shorrock​42​Chief Executive Officer and President​​​​​Beth Jantzen​48​Chief Financial Officer​​​​​Patrick Horsman​46​Chief Investment Officer​​​​​Joshua Kruger​34​Chairman of the Board of Directors​​​​​Robert B. Catell​88​Director​​​​​Joseph D. Ceccoli​62​Director​​​​​Yacov A. Shamash​75​Director​​​​​Elizabeth M. Schmalz Shaheen​74​Director​​​​​Judith Murrah​67​Director

​

Set forth below is biographical information with respect to the aforementioned individuals.

Executive Officers

Clay Shorrock has served as our Chief Executive Officer and President since September 2025 and our Chief Legal Officer and Executive Director of Business Development since April 2021, and as the President of LineaRx since December 2024. In his previous roles with the Company, Mr. Shorrock led the Company’s legal, regulatory, risk mitigation, intellectual property and business development functions and was instrumental in the development of the Company’s LineaDNA and LineaIVT platforms. Mr. Shorrock previously served as general and intellectual property counsel to the Company from November 2016 through April 2019. Prior to rejoining the Company in April 2021, Mr. Shorrock was a member of the intellectual property groups of Florida-based Lowndes, Drosdick, Doster, Kantor & Reed, P.A. from February 2020 until April 2021 and Allen, Dyer, Doppelt & Gilchrist, P.A. from May 2019 until January 2020. Earlier in his career Mr. Shorrock was an associate at several New Jersey-based law firms where he focused